Gut

1. WENG D, Chen J, Lin C
   Absolute risk stratification of HCC after HCV cure in MASLD: do advanced steatosis and dysglycaemia add beyond liver stiffness?
   Gut. 2026 Mar 2:gutjnl-2026-338294. doi: 10.1136/gutjnl-2026-338294.
   

   >> Share

   
   

   
   J Viral Hepat

2. THOMADAKIS C, Gountas I, Gountas K, Nuno N, et al
   Prevalence of Active HCV Infection in Spain in 2022 Using Multiparameter Evidence Synthesis.
   J Viral Hepat. 2026;33:e70159.
   

   >> Share

   
   
3. NIYOMSRI S, Lim AG, Arif A, Asim M, et al
   The Impact of Hepatitis C and Socio-Demographic Variables on Health-Related Quality of Life in Pakistan: Cross-Sectional Study.
   J Viral Hepat. 2026;33:e70139.
   

   >> Share

   
   

   
   Transplant Proc

4. KHURANA S, Gaines S, Kumarjiguda D, Kotru A, et al
   In Hepatitis C Virus-Negative Recipients of a Hepatitis C Virus-Infected Donor Kidney, Direct Antiviral Agent Therapy for 8 Weeks Is Noninferior to 12 Weeks.
   Transplant Proc. 2026 Mar 4:S0041-1345(26)00097.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share